semaglutide and pre-existing conditions Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, The Obesity Society Study Finds Oral Semaglutide Vastly
Description
A small study published in April in the New England Journal of Medicine found lixisenatideanother GLP-1 receptor agonist and close cousin of Wegovy and Ozempicslowed early Parkisons disease
The medication slows alcohol metabolism by 30-50%, increases blood alcohol concentrations by 20-40%, and extends intoxication duration
In addition, GLP- 1 has also been reported to augment cell proliferation and inhibit apoptosis in pancreatic endocrine cells
But the drugs narrative arc illustrates the definitive pattern for weight loss drugs
Seek medical attention if you cannot maintain hydration
